{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T05:51:37Z","timestamp":1779256297059,"version":"3.51.4"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T00:00:00Z","timestamp":1668816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001117","name":"The Foundation for AIDS Research","doi-asserted-by":"crossref","award":["109614-62-RGRL"],"award-info":[{"award-number":["109614-62-RGRL"]}],"id":[{"id":"10.13039\/100001117","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The HIV reservoir of latently infected CD4+ T cells represents the barrier to cure. CD4+ T-cell proliferation is a mechanism that sustains the reservoir even during prolonged antiretroviral therapy (ART). Blocking proliferation may therefore deplete the reservoir.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We conducted an unblinded, uncontrolled clinical trial of mycophenolate, a T-cell antiproliferative compound, in people with HIV on chronic suppressive ART. Study drug dose selection was based on calibration to an observed ex vivo antiproliferative effect. The primary outcome was clinically significant reduction (&amp;gt;0.25 log10) in the HIV reservoir, measured by total and intact HIV DNA per million T cells in blood over 48 weeks.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Five participants enrolled in the trial. Four participants took mycophenolate mofetil (MMF). One had a per-protocol switch to enteric-coated mycophenolate sodium (Myfortic) due to nausea but left the study for personal reasons. One participant developed finger cellulitis, but there were no opportunistic infections. In the 4 participants who completed the protocol, there was no clinically significant reduction in total or intact HIV DNA. There was no change in blood CD4+ T-cell subset composition within the HIV reservoir or the entire CD4+ T-cell population, although total CD4+ T cells decreased slightly in all 4 participants. An ex vivo antiproliferative effect was observed using participant serum obtained 1 hour after dosing, but this effect was severely diminished at drug trough.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Mycophenolate given over 48 weeks did not reduce the volume or composition of the HIV reservoir.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Clinical Trials registration<\/jats:title>\n                  <jats:p>NCT03262441.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ofid\/ofac620","type":"journal-article","created":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T22:38:46Z","timestamp":1668897526000},"source":"Crossref","is-referenced-by-count":7,"title":["Stable HIV Reservoir Despite Prolonged Low-Dose Mycophenolate to Limit CD4+ T-cell Proliferation"],"prefix":"10.1093","volume":"9","author":[{"given":"Joshua T","family":"Schiffer","sequence":"first","affiliation":[{"name":"Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Center , Seattle, Washington , USA"},{"name":"Clinical Research Division, Fred Hutchinson Cancer Center , Seattle, Washington , USA"},{"name":"Department of Medicine, University of Washington , Seattle, Washington , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Levy","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of Washington , Seattle, Washington , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean M","family":"Hughes","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of Washington , Seattle, Washington , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Urvashi","family":"Pandey","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of Washington , Seattle, Washington , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mel","family":"Padullo","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Washington , Seattle, Washington , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8212-3789","authenticated-orcid":false,"given":"Keith R","family":"Jerome","sequence":"additional","affiliation":[{"name":"Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Center , Seattle, Washington , USA"},{"name":"Department of Laboratory Medicine, University of Washington , Seattle, Washington , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiying","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, University of Washington , Seattle, Washington , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrina","family":"Puckett","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Washington , Seattle, Washington , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Helgeson","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Washington , Seattle, Washington , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert D","family":"Harrington","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Washington , Seattle, Washington , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Hladik","sequence":"additional","affiliation":[{"name":"Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Center , Seattle, Washington , USA"},{"name":"Department of Medicine, University of Washington , Seattle, Washington , USA"},{"name":"Department of Obstetrics and Gynecology, University of Washington , Seattle, Washington , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,11,19]]},"reference":[{"key":"2022121311134446600_ofac620-B1","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41586-019-0898-8","article-title":"A quantitative approach for measuring the reservoir of latent HIV-1 proviruses","volume":"566","author":"Bruner","year":"2019","journal-title":"Nature"},{"key":"2022121311134446600_ofac620-B2","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.cell.2013.09.020","article-title":"Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure","volume":"155","author":"Ho","year":"2013","journal-title":"Cell"},{"key":"2022121311134446600_ofac620-B3","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1126\/science.278.5341.1295","article-title":"Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy","volume":"278","author":"Finzi","year":"1997","journal-title":"Science"},{"key":"2022121311134446600_ofac620-B4","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nm880","article-title":"Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells","volume":"9","author":"Siliciano","year":"2003","journal-title":"Nat Med"},{"key":"2022121311134446600_ofac620-B5","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/infdis\/jiaa718","article-title":"Longitudinal dynamics of intact HIV proviral DNA and outgrowth virus frequencies in a cohort of individuals receiving antiretroviral therapy","volume":"224","author":"Falcinelli","year":"2021","journal-title":"J Infect Dis"},{"key":"2022121311134446600_ofac620-B6","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1093\/infdis\/jiv218","article-title":"Precise quantitation of the latent HIV-1 reservoir: implications for eradication strategies","volume":"212","author":"Crooks","year":"2015","journal-title":"J Infect Dis"},{"key":"2022121311134446600_ofac620-B7","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1097\/QAD.0000000000001948","article-title":"HIV DNA levels and decay in a cohort of 111 long-term virally suppressed patients","volume":"32","author":"Golob","year":"2018","journal-title":"AIDS"},{"key":"2022121311134446600_ofac620-B8","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1128\/JVI.01985-12","article-title":"An increasing proportion of monotypic HIV-1 DNA sequences during antiretroviral treatment suggests proliferation of HIV-infected cells","volume":"87","author":"Wagner","year":"2013","journal-title":"J Virol"},{"key":"2022121311134446600_ofac620-B9","doi-asserted-by":"crossref","first-page":"e20200051","DOI":"10.1084\/jem.20200051","article-title":"Antigen-responsive CD4+ T cell clones contribute to the HIV-1 latent reservoir","volume":"217","author":"Mendoza","year":"2020","journal-title":"J Exp Med"},{"key":"2022121311134446600_ofac620-B10","doi-asserted-by":"crossref","first-page":"E7908","DOI":"10.1073\/pnas.1617789113","article-title":"Paired quantitative and qualitative assessment of the replication-competent HIV-1 reservoir and comparison with integrated proviral DNA","volume":"113","author":"Lorenzi","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022121311134446600_ofac620-B11","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.cell.2015.01.020","article-title":"HIV-1 integration landscape during latent and active infection","volume":"160","author":"Cohn","year":"2015","journal-title":"Cell"},{"key":"2022121311134446600_ofac620-B12","doi-asserted-by":"crossref","first-page":"e60933","DOI":"10.7554\/eLife.60933","article-title":"Phenotypic analysis of the unstimulated in vivo HIV CD4 T cell reservoir","volume":"9","author":"Neidleman","year":"2020","journal-title":"Elife"},{"key":"2022121311134446600_ofac620-B13","doi-asserted-by":"crossref","first-page":"e145254","DOI":"10.1172\/JCI145254","article-title":"Antigen-driven clonal selection shapes the persistence of HIV-1-infected CD4+ T cells in vivo","volume":"131","author":"Simonetti","year":"2021","journal-title":"J Clin Invest"},{"key":"2022121311134446600_ofac620-B14","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1084\/jem.20170193","article-title":"Proliferation of latently infected CD4+ T cells carrying replication-competent HIV-1: potential role in latent reservoir dynamics","volume":"214","author":"Hosmane","year":"2017","journal-title":"J Exp Med"},{"key":"2022121311134446600_ofac620-B15","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1038\/s41467-020-17898-8","article-title":"Single-cell TCR sequencing reveals phenotypically diverse clonally expanded cells harboring inducible HIV proviruses during ART","volume":"11","author":"Gantner","year":"2020","journal-title":"Nat Commun"},{"key":"2022121311134446600_ofac620-B16","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/nm.1972","article-title":"HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation","volume":"15","author":"Chomont","year":"2009","journal-title":"Nat Med"},{"key":"2022121311134446600_ofac620-B17","first-page":"E2575","article-title":"Expanded cellular clones carrying replication-competent HIV-1 persist, wax, and wane","volume":"115","author":"Wang","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022121311134446600_ofac620-B18","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1093\/infdis\/jiv092","article-title":"Longitudinal genetic characterization reveals that cell proliferation maintains a persistent HIV type 1 DNA pool during effective HIV therapy","volume":"212","author":"von Stockenstrom","year":"2015","journal-title":"J Infect Dis"},{"key":"2022121311134446600_ofac620-B19","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1126\/science.1256304","article-title":"HIV latency. Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection","volume":"345","author":"Wagner","year":"2014","journal-title":"Science"},{"key":"2022121311134446600_ofac620-B20","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1172\/JCI135953","article-title":"Longitudinal study reveals HIV-1-infected CD4+ T cell dynamics during long-term antiretroviral therapy","volume":"130","author":"Antar","year":"2020","journal-title":"J Clin Invest"},{"key":"2022121311134446600_ofac620-B21","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1073\/pnas.1522675113","article-title":"Clonally expanded CD4+ T cells can produce infectious HIV-1 in vivo","volume":"113","author":"Simonetti","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022121311134446600_ofac620-B22","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1126\/science.1254194","article-title":"HIV latency. Specific HIV integration sites are linked to clonal expansion and persistence of infected cells","volume":"345","author":"Maldarelli","year":"2014","journal-title":"Science"},{"key":"2022121311134446600_ofac620-B23","doi-asserted-by":"crossref","first-page":"4811","DOI":"10.1038\/s41467-018-06843-5","article-title":"A majority of HIV persistence during antiretroviral therapy is due to infected cell proliferation","volume":"9","author":"Reeves","year":"2018","journal-title":"Nat Commun"},{"key":"2022121311134446600_ofac620-B24","doi-asserted-by":"crossref","first-page":"e1009214","DOI":"10.1371\/journal.ppat.1009214","article-title":"Relationship between CD4 T cell turnover, cellular differentiation and HIV persistence during ART","volume":"17","author":"Bacchus-Souffan","year":"2021","journal-title":"PLoS Pathog"},{"key":"2022121311134446600_ofac620-B25","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1084\/jem.20040341","article-title":"Rapid turnover of effector\u2013memory CD4+ T cells in healthy humans","volume":"200","author":"Macallan","year":"2004","journal-title":"J Exp Med"},{"key":"2022121311134446600_ofac620-B26","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1038\/s41598-017-04160-3","article-title":"Anti-proliferative therapy for HIV cure: a compound interest approach","volume":"7","author":"Reeves","year":"2017","journal-title":"Sci Rep"},{"key":"2022121311134446600_ofac620-B27","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/TP.0b013e318205568c","article-title":"Enteric-coated mycophenolate sodium versus mycophenolate mofetil in renal transplant recipients experiencing gastrointestinal intolerance: a multicenter, double-blind, randomized study","volume":"91","author":"Langone","year":"2011","journal-title":"Transplantation"},{"key":"2022121311134446600_ofac620-B28","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/ajt.12699","article-title":"Reduction of HIV persistence following transplantation in HIV-infected kidney transplant recipients","volume":"14","author":"Stock","year":"2014","journal-title":"Am J Transplant"},{"key":"2022121311134446600_ofac620-B29","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/77489","article-title":"Effects of mycophenolic acid on human immunodeficiency virus infection in vitro and in vivo","volume":"6","author":"Chapuis","year":"2000","journal-title":"Nat Med"},{"key":"2022121311134446600_ofac620-B30","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1097\/00126334-200407010-00009","article-title":"Effect of mycophenolate mofetil on immune response and plasma and lymphatic tissue viral load during and after interruption of highly active antiretroviral therapy for patients with chronic HIV infection: a randomized pilot study","volume":"36","author":"Garc\u00eda","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2022121311134446600_ofac620-B31","doi-asserted-by":"crossref","first-page":"100243","DOI":"10.1016\/j.xcrm.2021.100243","article-title":"A highly multiplexed droplet digital PCR assay to measure the intact HIV-1 proviral reservoir","volume":"2","author":"Levy","year":"2021","journal-title":"Cell Rep Med"},{"key":"2022121311134446600_ofac620-B32","doi-asserted-by":"crossref","first-page":"100885","DOI":"10.1016\/j.xpro.2021.100885","article-title":"HIV reservoir quantification by five-target multiplex droplet digital PCR","volume":"2","author":"Levy","year":"2021","journal-title":"STAR Protoc"},{"key":"2022121311134446600_ofac620-B33","doi-asserted-by":"crossref","first-page":"E3659","DOI":"10.1073\/pnas.1617961114","article-title":"Single-cell analysis of HIV-1 transcriptional activity reveals expression of proviruses in expanded clones during ART","volume":"114","author":"Wiegand","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022121311134446600_ofac620-B34","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1600-6143.2010.03413.x","article-title":"Mycophenolic acid-mediated suppression of human CD4+ T cells: more than mere guanine nucleotide deprivation","volume":"11","author":"He","year":"2011","journal-title":"Am J Transplant"},{"key":"2022121311134446600_ofac620-B35","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s00277-005-1070-0","article-title":"Mycophenolate mofetil for the treatment of acute and chronic steroid-refractory graft-versus-host disease","volume":"84","author":"Krejci","year":"2005","journal-title":"Ann Hematol"},{"key":"2022121311134446600_ofac620-B36","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1681\/ASN.2008101028","article-title":"Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis","volume":"20","author":"Appel","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"2022121311134446600_ofac620-B37","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.1182\/blood-2012-11-465625","article-title":"Interleukin-7 promotes HIV persistence during antiretroviral therapy","volume":"121","author":"Vandergeeten","year":"2013","journal-title":"Blood"},{"key":"2022121311134446600_ofac620-B38","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1093\/infdis\/jiab291","article-title":"Cellular activation, differentiation, and proliferation influence the dynamics of genetically intact proviruses over time","volume":"225","author":"Horsburgh","year":"2022","journal-title":"J Infect Dis"},{"key":"2022121311134446600_ofac620-B39","doi-asserted-by":"crossref","first-page":"674","DOI":"10.7326\/M18-0759","article-title":"Mechanisms that contribute to a profound reduction of the HIV-1 reservoir after allogeneic stem cell transplant","volume":"169","author":"Salgado","year":"2018","journal-title":"Ann Intern Med"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofac620\/47143508\/ofac620.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/9\/12\/ofac620\/47816388\/ofac620.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/9\/12\/ofac620\/47816388\/ofac620.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T11:14:34Z","timestamp":1670930074000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofac620\/6833354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,19]]},"references-count":39,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12,2]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofac620","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,12,1]]},"published":{"date-parts":[[2022,11,19]]},"article-number":"ofac620"}}